First-Line Combination Topical Therapy for Psoriasis

For patients with psoriasis requiring a structured topical regimen, evidence-based guidelines support a specific combination approach as the first line of treatment — one that balances efficacy with steroid-sparing principles.

Treatment Approach

The protocol is built around a steroid-sparing combination: a vitamin D analogue used together with a potent topical corticosteroid. This combination is guideline-recommended for the treatment of psoriasis. The complete regimen — including application instructions, schedule, and the full clinical algorithm — is detailed in the structured protocol.

Treatment Goal

The primary clinical target is clear or almost clear skin by 8 weeks. Evidence indicates the efficacy of vitamin D analogue–based combination therapy becomes apparent at 8 weeks.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jaad.2020.07.087

Agents such as vitamin D analogues, topical retinoids, and calcineurin inhibitors can be used as a maintenance treatment.
Use of combination treatments with vitamin D analogues and potent class II and class III topical corticosteroids up to 52 weeks is recommended for the treatment of psoriasis.
The efficacy of vitamin D analogues was noted at 8 weeks but not at 4 weeks.

View source ↗